Effects of the acetylcholinesterase inhibitor ENA-713 on ischemia-induced changes in acetylcholine and aromatic amine levels in the gerbil brain

K. Tanaka, N. Ogawa, Masato Asanuma, H. Hirata, Y. Kondo, N. Nakayama, A. Mori

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The effects of a new acetylcholinesterase inhibitor, ENA-713, on ischemia-induced changes in acetylcholine, monoamines, and their metabolites, were studied in the gerbil. ENA-713 (0.2 mg/kg) or saline was administered intraperitoneally to gerbils 30 min before induction of cerebral ischemia by bilateral carotid occlusion. Pretreatment with ENA-713 mitigated the ischemia-induced abnormalities of the cholinergic, dopaminergic and serotoninergic systems in the gerbil brain, although it had virtually no effect on acetylcholine, monoamines, or their metabolites in any region of the normal gerbil brain. These findings suggest that ENA-713 has beneficial effects against ischemia-induced cerebral disorders. Thus, ENA-713 seems to be promising as a preventive or therapeutic agent for cerebrovascular dementia due to cerebral ischemia and might be useful for the treatment of Alzheimer-type dementia which is associated with multiple neurotransmitter abnormalities in the brain.

Original languageEnglish
Pages (from-to)85-96
Number of pages12
JournalArchives Internationales de Pharmacodynamie et de Therapie
Volume323
Publication statusPublished - 1993

Fingerprint

Rivastigmine
Gerbillinae
Cholinesterase Inhibitors
Acetylcholine
Amines
Ischemia
Brain Ischemia
Brain
Multiple Abnormalities
Cholinergic Agents
Neurotransmitter Agents
Dementia
Alzheimer Disease

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effects of the acetylcholinesterase inhibitor ENA-713 on ischemia-induced changes in acetylcholine and aromatic amine levels in the gerbil brain. / Tanaka, K.; Ogawa, N.; Asanuma, Masato; Hirata, H.; Kondo, Y.; Nakayama, N.; Mori, A.

In: Archives Internationales de Pharmacodynamie et de Therapie, Vol. 323, 1993, p. 85-96.

Research output: Contribution to journalArticle

@article{b503e39640f648b89a430b021862e647,
title = "Effects of the acetylcholinesterase inhibitor ENA-713 on ischemia-induced changes in acetylcholine and aromatic amine levels in the gerbil brain",
abstract = "The effects of a new acetylcholinesterase inhibitor, ENA-713, on ischemia-induced changes in acetylcholine, monoamines, and their metabolites, were studied in the gerbil. ENA-713 (0.2 mg/kg) or saline was administered intraperitoneally to gerbils 30 min before induction of cerebral ischemia by bilateral carotid occlusion. Pretreatment with ENA-713 mitigated the ischemia-induced abnormalities of the cholinergic, dopaminergic and serotoninergic systems in the gerbil brain, although it had virtually no effect on acetylcholine, monoamines, or their metabolites in any region of the normal gerbil brain. These findings suggest that ENA-713 has beneficial effects against ischemia-induced cerebral disorders. Thus, ENA-713 seems to be promising as a preventive or therapeutic agent for cerebrovascular dementia due to cerebral ischemia and might be useful for the treatment of Alzheimer-type dementia which is associated with multiple neurotransmitter abnormalities in the brain.",
author = "K. Tanaka and N. Ogawa and Masato Asanuma and H. Hirata and Y. Kondo and N. Nakayama and A. Mori",
year = "1993",
language = "English",
volume = "323",
pages = "85--96",
journal = "Archives Internationales de Pharmacodynamie et de Therapie",
issn = "0003-9780",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Effects of the acetylcholinesterase inhibitor ENA-713 on ischemia-induced changes in acetylcholine and aromatic amine levels in the gerbil brain

AU - Tanaka, K.

AU - Ogawa, N.

AU - Asanuma, Masato

AU - Hirata, H.

AU - Kondo, Y.

AU - Nakayama, N.

AU - Mori, A.

PY - 1993

Y1 - 1993

N2 - The effects of a new acetylcholinesterase inhibitor, ENA-713, on ischemia-induced changes in acetylcholine, monoamines, and their metabolites, were studied in the gerbil. ENA-713 (0.2 mg/kg) or saline was administered intraperitoneally to gerbils 30 min before induction of cerebral ischemia by bilateral carotid occlusion. Pretreatment with ENA-713 mitigated the ischemia-induced abnormalities of the cholinergic, dopaminergic and serotoninergic systems in the gerbil brain, although it had virtually no effect on acetylcholine, monoamines, or their metabolites in any region of the normal gerbil brain. These findings suggest that ENA-713 has beneficial effects against ischemia-induced cerebral disorders. Thus, ENA-713 seems to be promising as a preventive or therapeutic agent for cerebrovascular dementia due to cerebral ischemia and might be useful for the treatment of Alzheimer-type dementia which is associated with multiple neurotransmitter abnormalities in the brain.

AB - The effects of a new acetylcholinesterase inhibitor, ENA-713, on ischemia-induced changes in acetylcholine, monoamines, and their metabolites, were studied in the gerbil. ENA-713 (0.2 mg/kg) or saline was administered intraperitoneally to gerbils 30 min before induction of cerebral ischemia by bilateral carotid occlusion. Pretreatment with ENA-713 mitigated the ischemia-induced abnormalities of the cholinergic, dopaminergic and serotoninergic systems in the gerbil brain, although it had virtually no effect on acetylcholine, monoamines, or their metabolites in any region of the normal gerbil brain. These findings suggest that ENA-713 has beneficial effects against ischemia-induced cerebral disorders. Thus, ENA-713 seems to be promising as a preventive or therapeutic agent for cerebrovascular dementia due to cerebral ischemia and might be useful for the treatment of Alzheimer-type dementia which is associated with multiple neurotransmitter abnormalities in the brain.

UR - http://www.scopus.com/inward/record.url?scp=0027431526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027431526&partnerID=8YFLogxK

M3 - Article

C2 - 8250645

AN - SCOPUS:0027431526

VL - 323

SP - 85

EP - 96

JO - Archives Internationales de Pharmacodynamie et de Therapie

JF - Archives Internationales de Pharmacodynamie et de Therapie

SN - 0003-9780

ER -